BioSpace News Archive

Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced that its Phase 2 study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction is now enrolling and recruiting in all multiple European and U.S. centers.

EuroFanColen researchers published in Nature Medicine first clinical results for Fanconi anemia patients

Their work, which appeared recently in Basic Research in Cardiology, elucidated transcriptomic signatures of these cardiomyocytes during induced cardiac hypertrophy.

Successful completion of Fractyl’s first sham-controlled, multicenter clinical trial of Revita DMR to support EU commercial launch and inform U.S. pivotal clinical trial

The volume of Tumor Treating Fields presentations marks a record number of abstracts for Novocure at one of the premier meetings for radiation oncologists

DURECT Corporation (Nasdaq: DRRX) announced today that further development of a long-acting injectable HIV investigational product utilizing DURECT’s SABER® technology has triggered a $10 million milestone payment from Gilead Sciences, Inc. to DURECT under the license agreement between the companies.

New BOOST® Soothe Nutritional Drink, Developed in Collaboration with Oncology Centers and Cancer Patients, Provides Nutritional Support for Patients Who Experience Certain Side Effects of Cancer Treatment

Johnson & Johnson Services Inc., Stryker Corp., Wright Medical Group NV, and Zimmer Biomet Holdings Inc. are competing for a bigger share of the healthcare industry, including health care equipment & services market, backed by the increasing investments in R&D, constant innovations and new product launches.

As concerns about Americans’ exposure to a certain group of chemical substances continues to grow, Battelle researchers have added another tool in their suite to help assess and understand occurrence.

Quantum Health, the leading healthcare and benefits consumer navigation and care coordination company, announced today that it is a featured speaker, presenting with key client, Portico Benefit Services, at the HEROForum19 on September 10-12 in Portland, Oregon.